Desferrioxamine as a lipid chain‐breaking antioxidant in sickle erythrocyte membranes

No abstract is available for this paper.

• Publication year

  1990

• Venue

  FEBS Letters

• Publication date

  1990-05-07

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-5793(90)80786-IPMID 2159892
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The nature of membrane-bound iron-species involved in radical-mediated damage to sickle erythrocytes

  1989cited by this paper
• A method for the comparative assessment of antioxidants as peroxyl radical scavengers.

  1989cited by this paper
• The interactions of desferrioxamine and hydroxypyridone compounds with haemoglobin and erythrocytes

  1989cited by this paper
• Membrane-associated iron-species and membrane oxidation in sickle-cell disease

  1989cited by this paper
• The suppression of iron release from activated myoglobin by physiological electron donors and by desferrioxamine.

  1989cited by this paper
• Generation of hydroxyl radicals by soybean nodule leghaemoglobin

  1988cited by this paper
• Excess heme in sickle erythrocyte inside-out membranes: possible role in thiol oxidation.

  1988cited by this paper
• Nonheme iron in sickle erythrocyte membranes: association with phospholipids and potential role in lipid peroxidation.

  1988cited by this paper
• Detection of peroxyl and alkoxyl radicals produced by reaction of hydroperoxides with heme-proteins by electron spin resonance spectroscopy.

  1988cited by this paper
• A method for removal of trace iron contamination from biological buffers

  1987cited by this paper
• The enzymatic oxidation of Desferal to a nitroxide free radical

  1987cited by this paper
• Desferrioxamine as an electron donor. Inhibition of membranal lipid peroxidation initiated by H2O2-activated metmyoglobin and other peroxidizing systems.

  1987cited by this paper
• Desferrioxamine (Desferal) and superoxide free radicals. Formation of an enzyme-damaging nitroxide.

  1987cited by this paper
• Role of membrane-bound haemoglobin products in oxidative damage in sickle cell membranes.

  1987cited by this paper
• Sickle cell membranes and oxidative damage.

  1986cited by this paper
• Iron-mediated free-radical effects on erythrocytes: the role of desferrioxamine

  1986cited by this paper
• Improved direct specific determination of serum iron and total iron-binding capacity.

  1980cited by this paper
• Quantitative studies of ferritinlike iron in erythrocytes of thalassemia, sickle-cell anemia, and hemoglobin Hammersmith with Mössbauer spectroscopy.

  1979cited by this paper
• Denatured hemoglobin in sickle erythrocytes.

  1977cited by this paper
• Ferrozine---a new spectrophotometric reagent for iron

  1970cited by this paper
• The Biochemistry of Desferrioxamine and its Relation to Iron Metabolism

  1964cited by this paper
• The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes.

  1963cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Guanidinylated bioactive chitosan-based injectable hydrogels with pro-angiogenic and mechanical properties for accelerated wound closure.

  2023cites this paper
• Design of a water-soluble chitosan-based polymer with antioxidant and chelating properties for labile iron extraction

  2023cites this paper
• Ultraviolet Light Protection: Is It Really Enough?

  2022cites this paper
• Effect of prooxidants and chelator Desferal on the oxidative status and sperm motility of Muscovy semen

  2022cites this paper
• Deferoxamine accelerates endothelial progenitor cell senescence and compromises angiogenesis

  2021cites this paper
• How to Improve the Antioxidant Defense in Asphyxiated Newborns—Lessons from Animal Models

  2020cites this paper
• Tert-Butyl Hydroperoxide Stimulated Apoptosis Independent of Prostaglandin E2 and IL-6 in the HTR-8/SVneo Human Placental Cell Line

  2020cites this paper
• Ciprofloxacin-induces free radical production in rat cerebral microsomes

  2019cites this paper
• Deferoxamine: An Angiogenic and Antioxidant Molecule for Tissue Regeneration

  2019cites this paper
• Quantifying Intranasally Administered Deferoxamine in Rat Brain Tissue with Mass Spectrometry.

  2019cites this paper
• Optimization of desferrioxamine E production by Streptomyces parvulus.

  2016cites this paper
• Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers

  2016cites this paper
• Transdermal deferoxamine prevents pressure-induced diabetic ulcers

  2014cites this paper
• Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease.

  2011cites this paper
• Investigating xanthine oxidase toxicity models in cultured cerebellar granule neurons.

  2009cites this paper
• Xanthine oxidase-induced neuronal death via the oxidation of NADH: prevention by micromolar EDTA.

  2009cites this paper
• High susceptibility of activated lymphocytes to oxidative stress-induced cell death.

  2008cites this paper
• Desferrioxamine (DFX) induces apoptosis through the p38-caspase8-Bid-Bax pathway in PHA-stimulated human lymphocytes.

  2008cites this paper
• Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice

  2005cites this paper
• Reactions of desferrioxamine with peroxynitrite-derived carbonate and nitrogen dioxide radicals.

  2004cites this paper
• Impairment of Macrophage Functions after Ingestion of Plasmodium s Erythrocytes or Isolated Malarial Pigment

  2003cites this paper
• Oxidative insult in sheep red blood cells induced by t-butyl hydroperoxide: The roles of glutathione and glutathione peroxidase

  2001cites this paper
• Effect of N-acetylcysteine and deferoxamine on endogenous antioxidant defense system gene expression in a rat hepatocyte model of cocaine cytotoxicity.

  2000cites this paper
• Sickle cell anemia: a potential nutritional approach for a molecular disease.

  2000cites this paper
• Dopamine induces cell death, lipid peroxidation and DNA base damage in a catecholaminergic cell line derived from the central nervous system

  1999cites this paper
• Inhibition of skeletal sarcoplasmic reticulum Ca2+-ATPase activity by deferoxamine nitroxide free radical.

  1999cites this paper
• The Role of Iron in Neurodegeneration

  1999cites this paper
• Prooxidant activity of ferrioxamine in isolated rat hepatocytes and linoleic acid micelles.

  1999cites this paper
• The ability of mineral dusts and fibres to initiate lipid peroxidation. Part I: parameters which determine this ability.

  1999cites this paper
• Pharmacological modulation of AGEs: a unique role for redox-active metal ions.

  1999cites this paper
• New modes of action of desferrioxamine: scavenging of semiquinone radical and stimulation of hydrolysis of tetrachlorohydroquinone.

  1998cites this paper
• Non-Chelation Dependent Redox Actions of Desferrioxamine

  1998cites this paper
• Antioxidant properties of desferrioxamine E, a new hydroxamate antioxidant

  1998cites this paper
• Inflammatory responses to ischemia, and reperfusion in skeletal muscle

  1998cites this paper
• Peroxidative damage in sickle-cell erythrocyte ghosts: protective effect of allopurinol.

  1997cites this paper
• MECHANISMS IN THE TOXICITY OF METAL IONS

  1995cites this paper
• Desferrioxamine inhibition of the hydroxyl radical-like reactivity of peroxynitrite: role of the hydroxamic groups.

  1995cites this paper
• Oxidative mechanisms in the toxicity of metal ions.

  1995cites this paper
• Antioxidant properties of deferoxamine

  1994cites this paper
• Oxidised low density lipoproteins induce iron release from activated myoglobin

  1993cites this paper
• The efficacy of monohydroxamates as free radical scavenging agents compared with di- and trihydroxamates.

  1993cites this paper
• Current status of antioxidant therapy.

  1993cites this paper
• Free radical-lipid interactions and their pathological consequences.

  1993cites this paper
• Stability of liposomal doxorubicin formulations: Problems and prospects

  1993cites this paper
• Oxidation of desferrioxamine to nitroxide free radical by activated human neutrophils.

  1993cites this paper
• [A comparative study of the antioxidant properties of polyhydroxamic acids, desferal and other iron chelating agents].

  1993cites this paper
• Free radicals, lipoproteins and cardiovascular dysfunction.

  1992cites this paper
• The role of free radicals in asbestos-induced diseases.

  1992cites this paper
• Detection of radicals produced by reaction of hydroperoxides with rat liver microsomal fractions.

  1992cites this paper
• Thiol compounds as protective agents in erythrocytes under oxidative stress.

  1992cites this paper
• Desferrioxamine enhances the reactivity of vanadium (IV) and vanadium (V) toward ferri- and ferrocytochrome c.

  1992cites this paper
• The chelation of nonheme iron within sickle erythrocytes by the hydroxypyridinone chelator CP094.

  1992cites this paper
• Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment [published erratum appears in J Exp Med 1993 Mar 1;177(3):following 873]

  1992cites this paper
• Failure of oxygen radical scavengers to modify fatigue in electrically stimulated muscle.

  1991cites this paper
• The formation of free radicals by cardiac myocytes under oxidative stress and the effects of electron-donating drugs.

  1991cites this paper
• FREE RADICALS, MYOCYTES AND REPERFUSION INJURY

  1991cites this paper
• Metalloproteins as donors of metal ions for oxygen chemistry

  1990cites this paper
• Free radicals, myocytes and reperfusion injury.

  1990cites this paper